A delayed clinical trial actually boosted Bristol Myers Squibb’s stock.
Here’s why.
-
Bristol Myers’ stock rallied Wednesday as investors maintained high hopes
for Cobenfy as an Alzheimer’s treatment, even though the outcome of a
late-stage ...
44 minutes ago







DEFUSE THE RAGE; STREET DEMONSTRATIONS ....http://english.aljazeera.net/programmes/insidestory/2011/08/2011889711816877.html
ReplyDelete